Tumor mutational load, CD8 [electronic resource]
Producer: 20200508Description: 771-777 p. digitalISSN:- 1432-0851
- Aged
- Antineoplastic Agents, Immunological -- pharmacology
- B7-H1 Antigen -- analysis
- Biomarkers, Tumor -- analysis
- Biopsy
- CD8-Positive T-Lymphocytes -- immunology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Decision-Making -- methods
- Disease Progression
- Female
- Follow-Up Studies
- Histocompatibility Antigens Class I -- analysis
- Humans
- Lung -- pathology
- Lung Neoplasms -- drug therapy
- Lymphocytes, Tumor-Infiltrating -- immunology
- Male
- Middle Aged
- Mutation Rate
- Nivolumab -- pharmacology
- Predictive Value of Tests
- Progression-Free Survival
- Proof of Concept Study
- Prospective Studies
- Response Evaluation Criteria in Solid Tumors
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.